Trial Profile
A randomized, double-blind, placebo-controlled, parallel-group, multi-centre, Phase IIb, study to determine the effect of BXL628 in women with detrusor overactivity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2019
Price :
$35
*
At a glance
- Drugs Elocalcitol (Primary)
- Indications Detrusor instability; Overactive bladder
- Focus Therapeutic Use
- Sponsors Cosmo Research & Development
- 25 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 23 May 2012 Results published in Urology.